Biospecifics Technologies (BSTC) Return on Assets ROA from the third quarter of 2020 to third quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biospecifics Technologies Corp  (NASDAQ: BSTC)


Biospecifics Technologies's ROA from the third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Biospecifics Technologies's ROA in the third quarter of 2020?
Biospecifics Technologies Corp achieved a return on average assets (ROA) of 13.07 % in its third quarter of 2020, which is below Biospecifics Technologies's average return on assets, which stands at 19.68%.

ROA fell compared to the second quarter of 2020, despite the net income growth of 4551.81% from the second quarter of 2020.

However, within the Healthcare sector 59 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2020 from 301 to 366.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Total Assets Change 15.87 % 19.55 % 25.76 % 26.54 % 26.64 %
Y / Y Net Income Change -14.13 % -98.2 % 1.86 % 18.92 % 24.39 %
Net Income (TTM) in million 17 18 25 24 23
Return On Assets (TTM) 13.07 % 14.25 % 20.03 % 21.14 % 21.36 %
BSTC's Total Ranking # 366 # 301 # 207 # 224 # 204
Total Assets (TTM) in million 137 134 133 127 118
Seq. Total Assets Change 2.61 % 0.4 % 5.21 % 6.91 % 5.87 %
Seq. Net Income Change 4551.81 % -97.43 % -38.82 % 17.23 % -2.39 %

BSTC's 5 Years Annual ROA >> Back to BSTC Management Effectiveness >> Compare BSTC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 28
Sector # 60
Overall # 356

Return On Assets Statistics
High Average Low
24.69 %
19.68 %
13.07 %
(Dec 31 2013)   (Sep 30 2020)





Financial Statements
Biospecifics Technologies's Assets $ 137 million BSTC's Balance sheet
Biospecifics Technologies's Income $ 5 million Quarterly BSTC's Income Statement
BSTC's Income by Division See BSTC's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change 26.54 % 33.46 % 15.92 % 41.57 % 47.29 %
Total Assets in million 127 100 75 65 46
Y / Y Net Income Change 22.02 % 77.02 % -0.39 % 18.24 % 107.01 %
Net Income in million 24 20 11 11 10
Annual Return On Assets 19.32 % 20.03 % 15.11 % 17.58 % 21.05 %

BSTC's 5 Years Annual ROA >> Back to BSTC Management Effectiveness >> Compare BSTC ROA to its Competitors



Comment on BSTC's ROA in the fiscal year ending 2019
In the fiscal year 2019 ROA deteriorated to 19.32 %, despite annual net income growth of 22.02 % to $24.47 million, from $20.05 million a year ago, as BSTC's assets increase to $126.65 million, by 22.02 %.


More Return On Assets Ratios
BSTC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BSTC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BSTC's Competitors
Subscribers only: Roa for Biospecifics Technologies's Suppliers
Subscribers only: Return On Assets for BSTC's Customers

You may also want to know
BSTC's Roi BSTC's Inventory Turnover Ratio BSTC's Growth Rates BSTC's Dividend Comparisons
BSTC's Profitability Ratios BSTC's Asset Turnover Ratio BSTC's Dividend Growth
BSTC's Roe BSTC's Valuation Ratios BSTC's Financial Strength Ratios BSTC's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2020, within Healthcare Sector ROA
Retractable Technologies Inc  35.69 %
Plx Pharma Inc   34.34 %
Innoviva Inc   33.39 %
Blueprint Medicines Corporation  33.35 %
Nrc Health  32.09 %
Viemed Healthcare Inc   28.37 %
Vertex Pharmaceuticals Inc  27.79 %
Coherus Oncology inc   26.56 %
Idexx Laboratories Inc  25.77 %
Ironwood Pharmaceuticals inc   25.44 %
Zynex inc   25.08 %
Lakeland Industries Inc   24.93 %
Corcept Therapeutics Inc  23.16 %
Integrated Biopharma Inc  21.94 %
Siga Technologies Inc  21.72 %
Pro dex Inc   21.57 %
Reflect Scientific Inc  21.22 %
Chemed Corporation  20.85 %
Mettler toledo International Inc   20.83 %
Lifevantage Corp  20.68 %
Regeneron Pharmaceuticals Inc   20.67 %
Seagen Inc   19.96 %
Biogen Inc   19.82 %
Waters Corporation  19.10 %
Abiomed Inc   16.66 %
Horizon Therapeutics Public Limited Company  16.63 %
Hologic Inc  16.45 %
Biomarin Pharmaceutical Inc  16.33 %
Royalty Pharma Plc  15.43 %
Resmed Inc   15.26 %

Date modified: 2026-09-26T07:12:56+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.